Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplant (allo HSCT)

Lignende værker

• The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma
  af: Jaglowski, Samantha M., et al.
  Udgivet: (2014)
• Atorvastatin for the Prophylaxis of Acute Graft vs. Host Disease (GVHD) in Patients Undergoing HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation (HSCT)
  af: Efebera, Yvonne A., et al.
  Udgivet: (2015)
• Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT
  af: Mammadli, Mahinbanu, et al.
  Udgivet: (2021)
• Improved non-relapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced intensity conditioning allogeneic transplantation for hematologic malignancies
  af: Hamadani, Mehdi, et al.
  Udgivet: (2009)
• Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
  af: Mammadli, Mahinbanu, et al.
  Udgivet: (2020)